# Considerations in Demonstrating Interchangeability With a Reference Product: Update - FDA Guidance Document Source: https://www.globalkeysolutions.net/guidances/guidance-document/considerations-in-demonstrating-interchangeability-with-a-reference-product-update/f154845a-a15e-4508-a634-dd22f907a286 > FDA guidance document: Considerations in Demonstrating Interchangeability With a Reference Product: Update. Issue date: June 21, 2024. Get complete insights and analysis. --- ## Details - Title: Considerations in Demonstrating Interchangeability With a Reference Product: Update - Communication Type: Guidance Document - Product Type: drugs - Office Name: Center for Drug Evaluation and Research - Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c - Issue Date: 2024-06-21 - Comment Close Date: 2024-08-20 - Last Changed: 2024-06-21 - Docket Number: FDA-2017-D-0154 ## Related Documents - [Scientific Considerations in Demonstrating Biosimilarity to a Reference Product: Updated Recommendations for Assessing the Need for Comparative Efficacy Studies: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/scientific-considerations-in-demonstrating-biosimilarity-to-a-reference-product-updated-recommendations-for-assessing-the-need-for-comparative-efficacy-studies-draft-guidance-for-industry/e314875c-585b-4d6e-bb97-b1b4f4edc32d) - [Real-World Evidence: Considerations Regarding Non-Interventional Studies for Drug and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/real-world-evidence-considerations-regarding-non-interventional-studies-for-drug-and-biological-products/48325e39-b445-4a53-8cc0-7483dcf3e352) - [Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/pregnant-women-scientific-and-ethical-considerations-for-inclusion-in-clinical-trials/674ff9d8-e752-4113-b7fd-bc85b7646bd3)